1-15 of 91
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Eye on Ocular HealthLogistical Considerations with Anti-VEGF Treatment in Wet AMD
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Eye on Ocular HealthDistinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Retinal Vein Occlusion: The Case for Prompt Treatment
Eye on Ocular HealthRetinal Vein Occlusion: The Case for Prompt Treatment
Identifying Central and Branch Retinal Vein Occlusion
Eye on Ocular HealthIdentifying Central and Branch Retinal Vein Occlusion
- advertisement
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Eye on Ocular HealthTime to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Outcomes for PDR Patients LTFU for at Least 1 Year
New Retina RadioOutcomes for PDR Patients LTFU for at Least 1 Year
Examining Therapeutic Timing in RVO-Related Macular Edema
Eye on Ocular HealthExamining Therapeutic Timing in RVO-Related Macular Edema
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
OphthalmologyReal-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Eye on Ocular HealthHow Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
- advertisement
Suprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
OphthalmologySuprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Eye on Ocular HealthTailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
